Objective: To assess the neonatal, current physical status, renal and developmental assessment of children born to renal allograft recipients (RAR) and to assess the psychological impact of successful childbirth on RAR and their families.
Introduction
The first successful pregnancy in a female following renal transplantation (RT) was reported in 1963 1 . Relatively little data is available regarding the outcome of pregnancies from female renal allograft recipients (RAR) 1 . For a woman with a functioning renal allograft to have a successful pregnancy is the best possible proof of rehabilitation from end stage renal disease (ESRD). Pregnancies in female RAR are considered as high risk and managed in tertiary care centres having a team of nephrologists, obstetricians and neonatologists to avoid unnecessary complications.
Objective
This study was undertaken to assess the neonatal, current physical status, renal and developmental assessment of children born to mothers who are RAR and to assess the psychological impact of successful childbirth on RAR and their families.
Method
A retrospective single centre cross-sectional prevalence survey carried out from January 2007 to January 2013 identified a total of 5 post renal transplant females of child bearing age who became pregnant. These female RAR and their children were assessed. Details of medication taken at the time of conception and throughout pregnancy, birth history and full paediatric history of children were gathered from parents using a semi-structured interview and questionnaire and confirmed using their posttransplant case records. Physical examination of the children including standard mercury sphygmomanometry was performed. The developmental assessment included child's gross motor, fine motor, adaptive, language, personal, social development and scholastic achievements. A single urine sample was collected for routine urinalysis as well as for microscopy and if required bacteriological examination. Ultrasound (US) examination of the child's abdomen including urinary tract was performed by one ultra-sonographer. The study was approved by the Institution Review Board. Informed consent was obtained from all participants. In the younger children Denver II, Gesell figure and Block skill were chosen as the most representative measures. One preterm-SGA newborn was admitted to the neonatal intensive care unit (NICU) for possibility of hypoglycaemia and icterus and was discharged on the 5 th day of life. This newborn required single surface phototherapy of 30 hours for physiological jaundice which developed on the 3 rd day of life. All other newborns were kept under observation in ward with mothers. Formula-feed was offered to all newborns. All passed urine in the first 6 hours and stool in the first 8 hours of life. All 3 were discharged on 3 rd postpartum day with their mothers. Two out of these 3 developed icterus neonatorum on 4 th and 5 th day of life noticed in well-baby clinic department, but did not require phototherapy. Their mean SCr was 0.32 (range: 0.26-0.4) mg/dl. None of them had congenital malformations or renal abnormalities on US. Neonatal reflexes were unremarkable in all.
Follow-up examination
One male and three females, ages ranging from 1 month and 5 days to 30 months, were studied at follow-up. The median age at time of assessment was 14.6 months with a mean weight of 7250 (range 2500-11,500)g. All were vaccinated according to their age. A comparison of babies born full term SGA and pre term SGA with full term and preterm AGA showed similar significant catch up growth. General health and physical assessment was unremarkable in all 4 children. Mean systolic and diastolic blood pressures (BP) were 68.25 (range 55-84) and 42 (range 32-54) mmHg respectively. Urinalysis was unremarkable at follow-up. Two children had recurrent respiratory tract infection. Development was considered normal according to age (table 2). 
Results
Maternal data: All 4 RAR are alive and well with normal functioning grafts. In all 4 female RAR, allograft function remained normal throughout pregnancy and puerperium. All were delivered by lower segment caesarian section (LSCS), 3 for obstetrical reasons and 1 electively. Post-partum phase was uneventful in all with mean SCr of 1.1 (range: 0.9-1.3) mg/dl. Mean maternal SCr at conception in those infants born with intrauterine growth retardation (IUGR) (BW<10 th centile for gestational age) did not differ significantly from those without IUGR. Complications during pregnancy resolved after delivery. Immunosuppression status was unchanged in all. Post-partum urine albumin was absent in all mothers and BP was controlled with the same anti-hypertensive medications.
Neonatal data: In this study, 50% infants were born prematurely (before completion of 37 weeks of gestation), and 50% had IUGR. No one had any congenital malformations noted. Neonatal death was absent in the study. Granulocytopenia was not seen in any of the children.
Discussion
Delivery of a normal child is possible in a RAR provided careful planning and monitoring of pregnancy is accomplished. The time interval between transplantation and conception should be ≥2 years of normal stable graft function (SCr<1.4 mg/dl), there should be absent or satisfactorily controlled hypertension, absent or minimal proteinuria and minimal immunosuppression with no evidence of active graft rejection or pelvicalyceal distension 5 .
The neonatal outcomes were generally good in our study group despite 50% incidence of risk factors such as prematurity and IUGR. In view of the prevalence of IUGR and preterm delivery, neonatal problems such as hypoglycaemia, icterus neonatorum and RDS are predictable. There were no RDS created problems in our study group possibly due to use of maternal corticosteroids prior to delivery
Maternal immunosuppression is of critical importance in maintaining stable renal allograft function without any adverse influence on the developing embryo and fetus. Prednisolone has been shown to cause preterm birth in animal models 6 . Neonatal adrenal insufficiency has been described in human infants of transplanted mothers exposed to corticosteroids 7, 8, 9 and azathioprine has been associated with skeletal and central nervous system anomalies in animals 10, 11 .
There is a risk of complications for both the fetus and mother with 25% chances of spontaneous abortion and 50-66% chances of IUGR and/or premature delivery 12 . Abortions were noted in two RAR in our study, one of whom had 2 abortions in the first trimester within one year of RT. She was advised to conceive after a total duration of 2 years of RT. Aramenti et al have reported that transplant interval of shorter duration (<1-2 years) was associated with greater risk of unsatisfactory outcome, and that longer interval (>5 years) after transplantation was associated with lower incidence of prematurity and low birth weight. Thus, women should be advised to use optimal contraception in the first 2 years after RT 13 .
No pattern of fetal anomalies has emerged with maternal corticosteroids, azathioprine, tacrolimus or cyclosporine in either animal model or in humans, though LBW and premature deliveries are associated with immunosuppressive agents 6, 14, 15, 16 . Fortunately we did not encounter any anomalies in our study group. The children in our study, while tending to be premature and small, have shown very impressive catch-up growth. As far as we know, this has not been previously reported. This suggests that postnatal progress is not adversely influenced by maternal immunosuppression or renal function.
Little data is available on breast-feeding by mothers taking immunosuppressive medication. The American Association of Paediatrics supports breast-feeding by mothers taking prednisolone, advises against breast-feeding by those taking cyclosporine, and provides no recommendations regarding azathioprine or tacrolimus. Whether the risk of exposure to immunosuppression through breast milk outweighs the benefits of breast-feeding, remain unknown 17 .
Child development and general health were normal in our study group. Developmental delay reported in other studies may be due to perinatal asphyxia rather than being related to the maternal renal allograft or immunosuppression.
There are numerous psychological issues arising in families of a female RAR. These include maternal anxiety regarding her own health as well as of her children. Almost all mothers in our study were apprehensive initially about the possibility of renal disease in their children, often without raising the issue with their paediatrician. There is a paucity of literature concerning psychological development within these families although one study suggests that most children develop without behavioural problems and that most parents are 'well adjusted', though having a low threshold for seeking medical attention for their children 18 .
BP was normal in all children, though there is some support for the suggestion put forward by Barker and others, of birth weight being inversely related to subsequent BP 19, 20 .
One purpose of our study was to consider the renal outcome of all children of RAR. Children underwent haematological, urinalysis, SCr and radiology investigations to rule out granulocytopenia, abnormal renal function and congenital anomaly. US although relatively crude screen with regards to vesico-ureteric reflux. Renal tract abnormality was absent in our study.
In our RT population, patients' own wish to become a mother and conceive a baby was decisive. Social factors had no marked influence on patient's decisions for pregnancy in our study.
In developing countries, regretfully many of these pregnancies are not planned, the allograft recipient being unaware that they could conceive and therefore they take prenatal care quite late in gestation. Patients therefore must be referred to highly specialized centres where obstetricians, nephrologists, intensivists, and neonatologists provide surveillance and treatment 21 .
Conclusions
• Childbirth in renal allograft recipients (RAR) with stable graft function improves social quality of life of families.
• Post-natal progress is not adversely influenced by immunosuppression of RAR.
• Preterm-delivery and intrauterine growth retardation remain risk factors.
This small report is likely to stimulate our colleagues in developing countries, who are still uncertain about the pregnancies in female RAR, and help them to revise their views. It seems prudent on the part of treating physicians to discuss the possibility of having a baby with their patients in appropriate clinical circumstances.
